These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 23711626

  • 1. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L.
    Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626
    [Abstract] [Full Text] [Related]

  • 2. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P, Coëffier M.
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [Abstract] [Full Text] [Related]

  • 3. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Edogawa S, Edwinson AL, Peters SA, Chikkamenahalli LL, Sundt W, Graves S, Gurunathan SV, Breen-Lyles M, Johnson S, Dyer R, Graham R, Chen J, Kashyap P, Farrugia G, Grover M.
    Gut; 2020 Jan; 69(1):62-73. PubMed ID: 30923071
    [Abstract] [Full Text] [Related]

  • 4. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M.
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [Abstract] [Full Text] [Related]

  • 5. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L.
    Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
    [Abstract] [Full Text] [Related]

  • 6. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bôle-Feysot C, Déchelotte P, Reimund JM, Ducrotté P.
    Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
    [Abstract] [Full Text] [Related]

  • 7. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M, Harkat C, Bzioueche H, Cartier C, Plichon-Dainese R, Moussa L, Eutamene H, Pishvaie D, Holowacz S, Seyrig C, Piche T, Theodorou V.
    World J Gastroenterol; 2014 Jun 14; 20(22):6832-43. PubMed ID: 24944474
    [Abstract] [Full Text] [Related]

  • 8. Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients.
    Wang P, Chen FX, Du C, Li CQ, Yu YB, Zuo XL, Li YQ.
    Sci Rep; 2015 May 22; 5():10121. PubMed ID: 25998025
    [Abstract] [Full Text] [Related]

  • 9. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L, Eutamene H.
    Pain; 2009 Jul 22; 144(1-2):209-17. PubMed ID: 19450926
    [Abstract] [Full Text] [Related]

  • 10. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
    Castro J, Harrington AM, Hughes PA, Martin CM, Ge P, Shea CM, Jin H, Jacobson S, Hannig G, Mann E, Cohen MB, MacDougall JE, Lavins BJ, Kurtz CB, Silos-Santiago I, Johnston JM, Currie MG, Blackshaw LA, Brierley SM.
    Gastroenterology; 2013 Dec 22; 145(6):1334-46.e1-11. PubMed ID: 23958540
    [Abstract] [Full Text] [Related]

  • 11. Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome.
    Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, Dong YY, Wang P, Li YQ.
    Gut; 2012 May 22; 61(5):685-94. PubMed ID: 21997550
    [Abstract] [Full Text] [Related]

  • 12. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, Hébuterne X, Piche T.
    Gut; 2014 May 22; 63(5):744-52. PubMed ID: 23878165
    [Abstract] [Full Text] [Related]

  • 13. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM, Gong J, Dong L, Xu JR.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep 22; 27(9):1345-7. PubMed ID: 17884774
    [Abstract] [Full Text] [Related]

  • 14. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M.
    Gut; 2013 Aug 22; 62(8):1160-8. PubMed ID: 22637702
    [Abstract] [Full Text] [Related]

  • 15. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2.
    Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ.
    Am J Gastroenterol; 2013 Oct 22; 108(10):1634-43. PubMed ID: 23958521
    [Abstract] [Full Text] [Related]

  • 16. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, Corinaldesi R, Barbara G.
    Am J Gastroenterol; 2011 Jul 22; 106(7):1290-8. PubMed ID: 21427712
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L.
    Clin Gastroenterol Hepatol; 2007 May 22; 5(5):550-5. PubMed ID: 17336590
    [Abstract] [Full Text] [Related]

  • 18. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L, Long Y, Kim JJ, Chen B, Zhu Y, Dai N.
    Dig Dis Sci; 2019 Mar 22; 64(3):729-739. PubMed ID: 30446929
    [Abstract] [Full Text] [Related]

  • 19. Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Bertrand J, Ghouzali I, Guérin C, Bôle-Feysot C, Gouteux M, Déchelotte P, Ducrotté P, Coëffier M.
    JPEN J Parenter Enteral Nutr; 2016 Nov 22; 40(8):1170-1176. PubMed ID: 25972430
    [Abstract] [Full Text] [Related]

  • 20. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct 22; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.